Use of ginsenoside M1 for treating lupus nephritis
US9844560B2 · kind B2 · utility
3Cited by
2References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 4, 2015 |
| Grant date | Dec 19, 2017 |
| Priority date | — |
| Expiry date | May 4, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method of treating a subject afflicted with lupus nephritis comprising administering to the subject an amount of ginsenoside M1 effective to treat the subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.